Ishraq Hussain

Dr. Ishraq Hussain

Biochemistry, Sher-e-Kashmir University of Agricultural Sciences and Technology of Kashmir, Srīnagar, Jammu and Kashmīr, International
orcid

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2015 in The Scientific World Journal
Verified
Journal Article
Open access
PDF file
BABilal Ahmad
Bilal Ahmad
MRMuneeb U Rehman
Muneeb U Rehman
IAInsha Amin
Insha Amin
AAAhmad Arif
Ahmad Arif
SRSaiema Rasool
Saiema Rasool
MMManzoor Ur Rahman Mir
Manzoor Ur Rahman Mir
Humans have been using natural products for medicinal use for ages. Natural products of therapeutic importance are compounds derived from plants, animals, or any microorganism. Ginger is also one of the most commonly used condiments and a natural drug in vogue. It is a traditional medicine, having some active ingredients used for the treatment of numerous diseases. During recent research on ginger, various ingredients like zingerone, shogaol, and paradol have been obtained from it. Zingerone (4‐(4‐hydroxy‐3‐methoxyphenyl)‐2‐butanone) is a nontoxic and inexpensive compound with varied pharmacological activities. It is the least pungent component of Zingiber officinale. Zingerone is absent in fresh ginger but cooking or heating transforms gingerol to zingerone. Zingerone closely related to vanillin from vanilla and eugenol from clove. Zingerone has potent anti‐inflammatory, antidiabetic, antilipolytic, antidiarrhoeic, antispasmodic, and so forth properties. Besides, it displays the property of enhancing growth and immune stimulation. It behaves as appetite stimulant, anxiolytic, antithrombotic, radiation protective, and antimicrobial. Also, it inhibits the reactive nitrogen species which are important in causing Alzheimer’s disease and many other disorders. This review is written to shed light on the various pharmacological properties of zingerone and its role in alleviating numerous human and animal diseases.

10 June 2013 in Journal of Experimental Medicine
Verified
Journal Article
Open access
PDF file
UHUzma Hasan
Uzma Hasan
CZClaudia Zannetti
Claudia Zannetti
PPPeggy Parroche
Peggy Parroche
NGNadège Goutagny
Nadège Goutagny
MMMarine Malfroy
Marine Malfroy
MTMassimo Tommasino
Massimo Tommasino
Human papillomavirus type 16 (HPV16) and other oncogenic viruses have been reported to deregulate immunity by suppressing the function of the double-stranded DNA innate sensor TLR9. However, the mechanisms leading to these events remain to be elucidated. We show that infection of human epithelial cells with HPV16 promotes the formation of an inhibitory transcriptional complex containing NF-κBp50–p65 and ERα induced by the E7 oncoprotein. The E7-mediated transcriptional complex also recruited the histone demethylase JARID1B and histone deacetylase HDAC1. The entire complex bound to a specific region on the TLR9 promoter, which resulted in decreased methylation and acetylation of histones upstream of the TLR9 transcriptional start site. The involvement of NF-κB and ERα in the TLR9 down-regulation by HPV16 E7 was fully confirmed in cervical tissues from human patients. Importantly, we present evidence that the HPV16-induced TLR9 down-regulation affects the interferon response which negatively regulates viral infection. Our studies highlight a novel HPV16-mediated mechanism that combines epigenetic and transcriptional events to suppress a key innate immune sensor.

9 June 2020 in Journal of Food Biochemistry
Verified
Journal Article
Closed access
PDF file
IAInsha Amin
Insha Amin
IHIshraq Hussain
Ishraq Hussain
MRMuneeb U Rehman
Muneeb U Rehman
BMBilal Ahmad Mir
Bilal Ahmad Mir
SGShowkat Ahmad Ganaie
Showkat Ahmad Ganaie
Parvaiz AhmadParvaiz Ahmad
Parvaiz Ahmad

1 December 2018 in Saudi Pharmaceutical Journal
Verified
Journal Article
Open access
BABilal Ahmad
Bilal Ahmad
MRMuneeb U. Rehman
Muneeb U. Rehman
IAInsha Amin
Insha Amin
MMManzoor Ur Rahman Mir
Manzoor Ur Rahman Mir
SASheikh B Ahmad
Sheikh B Ahmad
BFBilques Fatima
Bilques Fatima
Diabetes is considered as the most common metabolic disease affecting millions of people all around the world. Use of natural herbal medicines can be effective in treating diabetes. Zingerone (4-(4-hydroxy-3-methylphenyl) butan-2-one) a polyphenolic alkanone extracted from ginger has a broad spectrum of pharmacological properties and thus can be used as a promising candidate against various ailments. In the current study we aimed at demonstrating the protective effect of zingerone against diabetes mellitus and elucidating its possible mechanism. Five groups of animals (I-V) were made with ten animals each. Group I (control) was given normal saline orally. Group II (diabetic positive control) was given alloxan at the dose rate of 100 mg/kg bwt once. Group III and IV was given alloxan once at the dose rate of 100 mg/kg bwt. and received oral treatment of zingerone at a dose rate of 50 and 100 mg/kg bwt respectively daily for 21 days. Group V was given alloxan at the dose of 100 mg/kg bwt. and was treated with standard drug glibenclamide at the dose rate of 4.5 mg/kg bwt. daily for 21 days. According to our findings we confirmed that zingerone restrained the alloxan induced oxidative stress by increasing the activity of reduced glutathione (GSH), superoxide dismutase (SOD), catalase (CAT), glutathione peroxidase (GPX) and reducing the peroxidative damage. We also confirmed that zingerone suppressed the level of redox sensitive transcription factor NFκB and downregulated other downstream inflammatory cytokines like interleukins (IL1-β IL-2, IL-6) and tumor necrosis factor alpha (TNF-α). Moreover, the experimental findings suggested that zingerone improved the insulin levels. Taken together our results indicated that zingerone effectively ameliorated the diabetes induced complications which provide a strong theoretical basis for zingerone to be used clinically for treatment of diabetes.

18 January 2018 in Environmental Toxicology
Verified
Journal Article
Closed access
PDF file
MRMuneeb U Rehman
Muneeb U Rehman
MMManzoor Ur Rahman Mir
Manzoor Ur Rahman Mir
AFAdil Farooq
Adil Farooq
SRShahzada Rashid
Shahzada Rashid
BABilal Ahmad
Bilal Ahmad
MGMajid Ahmad Ganaie
Majid Ahmad Ganaie

18 December 2017 in Environmental Toxicology
Verified
Journal Article
Closed access
PDF file
SASheikh B Ahmad
Sheikh B Ahmad
MRMuneeb U. Rehman
Muneeb U. Rehman
BFBilques Fatima
Bilques Fatima
BABilal Ahmad
Bilal Ahmad
IHIshraq Hussain
Ishraq Hussain
MMManzoor Ur Rahman Mir
Manzoor Ur Rahman Mir